Skip to search formSkip to main contentSkip to account menu

L 754030

Known as: L 754,030, L-754,030, L-754030 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
The introduction of serotonin 5-HT3 receptor antagonists into clinical practice allowed for a dramatic improvement in the… 
2006
2006
1. Pandey CK, Priye S, Ambesh SP, Singh S, Singh U, Singh PK. Prophylactic gabapentin for prevention of postoperative nausea and… 
Review
2005
Review
2005
OBJECTIVE: To evaluate the safety and efficacy of aprepitant in the prevention of acute and delayed chemotherapy-induced nausea… 
Highly Cited
2001
Highly Cited
2001
PURPOSE The NK1-receptor antagonist MK-869 (L-754,030) has demonstrated antiemetic activity in humans receiving chemotherapy… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND The localization of substance P in brain-stem regions associated with vomiting, and the results of studies in ferrets… 
1999
1999
AIMS Following intravenous administration of its prodrug, L-758,298, we assessed the pharmacodynamics of L-754,030, a novel and… 
Review
1999
Review
1999
Chemotherapy-induced nausea and vomiting are important, distressing, and occasionally disabling problems that confound the…